Skip to main content

Table 1 Baseline and stimulation cycle characteristics

From: AMH independently predicts aneuploidy but not live birth per transfer in IVF PGT-A cycles

 

No normal embryos (n = 2100)

 ≥ 1 presumed euploid embryo (n = 8778)

 

Age (years)

40.0 (3.2)

37.0 (3.7)

P < 0.001

AMH (ng/ml)

1.9 (2.4)

3.5 (3.5)

P < 0.001

BMI (kg/m2)

24.9 (5.2)

24.9 (5.3)

P = 0.58

Race

  

P < 0.001

 White

798 (38.0%)

3382 (38.5%)

 American Indian/Alaskan Native

1 (0.05%)

8 (0.1%)

 Asian

266 (12.7%)

938 (10.7%)

 Black/ African American

84 (4.0%)

246 (2.8%)

 Hispanic/Latina

99 (4.7%)

331 (3.8%)

 Hawaiian/ Pacific Islander

4 (0.2%)

9 (0.1%)

 Multiracial

11 (0.5%)

49 (0.6%)

 Unknown

837 (39.9%)

3815 (43.5%)

Infertility etiology

 Male factor

617 (29.4%)

2640 (30.1%)

P = 0.49

 Endometriosis

139 (6.6%)

596 (6.8%)

P = 0.82

 PCOS

81 (3.9%)

945 (10.8%)

P < 0.001

 DOR

1289 (61.4%)

2908 (33.1%)

P < 0.001

 Tubal factor

200 (9.5%)

859 (9.8%)

P = 0.75

 Uterine factor

283 (13.5%)

833 (9.5%)

P < 0.001

 Unexplained

116 (5.5%)

978 (11.1%)

P < 0.001

Stimulation characteristics

 FSH dosage (IU)

4406 (1549)

3669 (1577)

P < 0.001

 No. eggs retrieved

10.1 (6.7)

16.4 (9.0)

P < 0.001

 No. embryos cryopreserved

2.5 (1.7)

4.6 (2.4)

P < 0.001